Malignant transformation of uterine serosal endometriosis to clear cell carcinoma in a postmenopausal patient: a rare case report [0.03%]
绝经后患者浆膜内异症恶变为透明细胞癌一例罕见病例报告
Xiaodong Mi,Tong Lin,Xiaogang Zhu et al.
Xiaodong Mi et al.
Background: Endometriosis is a prevalent benign condition among women of reproductive age. While the overall rate of endometriosis-associated malignancy is low, the risk of malignant transformation increases significantly...
Coencapsulation of doxorubicin and curcumin in liposomes modified with folic acid for reversal of drug resistance in glioma [0.03%]
叶酸修饰的载多西他赛-姜黄素脂质体逆转胶质瘤耐药性的研究
Zhan Wang,Ze Zhao,Yang Yang et al.
Zhan Wang et al.
Introduction: Multidrug resistance (MDR) critically limits doxorubicin (Dox) efficacy in glioma. To overcome this, we constructed a folic acid receptor (FAR)-targeted liposomal system for codelivering Dox and curcumin (Cu...
Predictors of false-negative serum thyroglobulin in persistent/recurrent Papillary Thyroid Carcinoma cervical lymph nodes [0.03%]
甲状腺乳头状癌颈部淋巴结持续/复发的假阴性血清甲状腺球蛋白的影响因素分析
Jing Lin,Alibiyati Aini,Zien Qin
Jing Lin
Purpose: Serum thyroglobulin (Tg) is the primary biomarker for monitoring disease persistence and recurrence in papillary thyroid carcinoma (PTC). However, some patients with structurally confirmed persistent/recurrent ce...
Enhanced differentiation of breast lesions through integration of microvascular flow imaging and machine learning algorithms [0.03%]
通过集成微血管血流成像和机器学习算法提高乳腺病变的鉴别能力
Fangfang Zhou,Wanling Lin,Jiqin Yao et al.
Fangfang Zhou et al.
Introduction: Breast cancer diagnosis relies on imaging, yet conventional Doppler ultrasound possesses limitations in visualizing tumor microvasculature. This study aimed to compare Microvascular Flow imaging (MV-Flow) wi...
The long road after breast cancer: survivorship issues and long-term treatment effects in young women [0.03%]
年轻女性乳腺癌患者治疗后的长期生存问题及远期治疗效应
Martina Pagliuca,Roberto Buonaiuto,Annarita Verrazzo et al.
Martina Pagliuca et al.
Advances in early detection and treatment have significantly improved survival rates in young women with breast cancer, leading to a growing population of long-term survivors. However, survivorship in this population is characterized by a u...
Decoding amino acid metabolism in hepatocellular carcinoma: critical nodes and novel therapeutic strategy [0.03%]
肝细胞癌中氨基酸代谢的解码:关键节点和新型治疗策略
Jiayi Zhang,Yiling Zhu,Guiyan Liu et al.
Jiayi Zhang et al.
Amino acid metabolic reprogramming is one of the crucial features of metabolic remodeling in HCC. Accumulating evidence indicates that specific amino acid metabolisms play essential roles in promoting HCC cell proliferation and the developm...
Analysis of risk factors and prediction of prognosis in patients with primary liver cancer undergoing transarterial chemoembolization [0.03%]
经导管动脉化疗栓塞治疗原发性肝癌风险因素分析及预后判断
Xu-Long Lu,Li-Min Yin
Xu-Long Lu
Background: Transarterial chemoembolization (TACE) is a key locoregional therapy for unresectable primary liver cancer, yet post-TACE survival remains heterogeneous. We evaluated prognostic determinants and developed a pr...
Early detection of multiple cancers: the era of methylation-based liquid biopsy [0.03%]
基于甲基化的液体活检技术引领癌症早筛新时代
Yajie Lin,Zekai Hu,Leyao Shuai et al.
Yajie Lin et al.
Liquid biopsy based on circulating cell-free DNA (cfDNA) methylation has become a leading non-invasive strategy for multi-cancer early detection (MCED). Aberrant DNA methylation arises at the early stage of tumorigenesis and displays cancer...
Multi-omics and spatial transcriptomics decode the ZDHHC9-driven hypoxia-immunosuppressive axis in hepatocellular carcinoma [0.03%]
多组学和空间转录组学解码ZDHHC9驱动的肝细胞癌低氧免疫抑制轴
Haiyan Lu,Lingzhen Kong,Shidong Hu et al.
Haiyan Lu et al.
Background: Hepatocellular carcinoma (HCC) is a major global health challenge with limited treatment options, highlighting the urgent need for new biomarkers and therapeutic targets. Protein palmitoylation, mediated by ZD...
Editorial: Innovative strategies in overcoming glioblastoma: advancements in treatment and research [0.03%]
editorial:克服胶质母细胞瘤的创新策略:治疗和研究方面的进展
Raphael Bertani,Fabio Torregrossa,Felipe Salvagni
Raphael Bertani